TCR2 Therapeutics Inc (NASDAQ:TCRR)

1.18
Delayed Data
As of Dec 08
 -0.08 / -6.35%
Today’s Change
1.14
Today|||52-Week Range
5.41
-74.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
Revenue and IncomeNet Revenues0.000.000.00----
Depreciation And Amortization220.0K298.0K419.0K--
 
 
 
 
 
Operating ExpensesGross Income-220.0K-298.0K-419.0K--
 
 
 
 
General Expenses9.7M12.9M26.0M--
 
 
 
 
Research And Development7.7M9.6M19.3M--
 
 
 
 
Total Operating Expenses9.9M13.2M26.5M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.9M-13.2M-26.5M--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.9M-13.1M-24.3M--
 
 
 
 
Preferred Dividend-787.0K-1.8M-37.3M--
 
 
 
 
Net Income-9.9M-13.1M-24.3M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.9M23.9M23.9M--
 
 
 
 
Shares To Calculate EPS Diluted23.9M23.9M23.9M--
 
 
 
 
 
Earnings Per ShareEPS-$0.45-$0.62-$2.57--
 
 
 
 
EPS Diluted-$0.45-$0.62-$2.57--